Oncology Business Management | Specialty

Intellectual Conflicts of Interest Pose Hidden Dangers to Scientific Accuracy

February 1st 2019

The model of an independent and self-regulating academic medical community continues to be challenged through widely reported accusations of serious scientific misconduct, failure of investigators to report potential financial conflicts of interest, and suggestions of inadequate transparency related to the questionable role of academic researchers in the analysis and reporting of industry-sponsored clinical trial results.

Overcoming Acquired Resistance Mechanisms in BRAF+ mCRC

January 31st 2019

First-Line Triplet in BRAF+ mCRC

January 31st 2019

Real-World Management of Patients with BRAF-V600E mCRC

January 31st 2019

CRC Safety Lead-in: ASCO GI 2019 Updates

January 31st 2019

Combining BRAF, MEK and EGFR Inhibition in mCRC

January 31st 2019

Lack of Durable Responses in Current Treatment of mCRC

January 31st 2019

Sequencing Strategies in BRAF-Mutated mCRC

January 31st 2019

Prognosticating BRAF-Mutant mCRC

January 31st 2019

Expert Discusses How Data Informatics Is Driving Drug Development

January 29th 2019

Subha Madhavan, PhD, discusses the role of data science and informatics in bringing novel clinical study designs to the field of oncology.

Blood Cancers Associated With Higher Treatment and Out-of-Pocket Costs

January 25th 2019

Patients with blood cancers face greater treatment costs than those with solid tumors. Furthermore, healthcare spending for these patients is already higher than average before diagnosis and does not return to prediagnosis levels even after successful treatment.

Be More Sensitive to the Toxicities of Cancer Therapy

January 16th 2019

The concept of chronic disease management in cancer has been and continues to be inadequately considered.

AI Will Converge With Physician-Directed Care

January 5th 2019

Improvements and greater familiarity with artificial intelligence will lead to systems of checks and balances that will create trust and fulfill the promise of computer-assisted precision medicine.

How Your Oncology Peers Manage the Complexities of Care

December 14th 2018

Consciously or unconsciously, all oncologists develop some sort of system for managing the growing complexity of cancer care.

Hospital Lauded for Innovative Solution to Drug Waste Problem

November 7th 2018

Within a year of starting its drug-waste reduction study in 2010, NCCH became the first hospital in the country to implement a program systematically extending medications’ beyond use dates from several hours to upward of 7 days.

New Law Widens Access to Genetic Counseling but Licensure and Coverage Barriers Persist

October 9th 2018

Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.

340B Advantage for Hospitals Starts to Erode

October 3rd 2018

The battle over 340B continues in Congress, with multiple legislative initiatives.

Oncology Care Model Practices Await CMS Report Cards

September 3rd 2018

Alyssa Dahl, MPH, CPH, discusses what to watch for when the CMS releases performance results for the Oncology Care Model.

FDA Grants Full Approval to Pembrolizumab Plus Chemo for NSCLC

August 20th 2018

The FDA has granted a full approval to frontline pembrolizumab for use in combination with standard chemotherapy for patients with metastatic nonsquamous non–small cell lung cancer.

CMS Decision Helps Unlock the Potential of Next-Generation Testing

August 17th 2018

Provisions to a final national coverage determination that expanded coverage for next-generation sequencing tests have implications for any NGS-based cancer test provided to Medicare beneficiaries and will inevitably influence the coverage thinking of commercial payers.